Navigation Links
FDA Curbs Use of Certain Antibiotics in Livestock, Poultry
Date:1/5/2012

WEDNESDAY, Jan. 4 (HealthDay News) -- Worried about the growing threat of antibiotic-resistant microbes in humans, the U.S. Food and Drug Administration on Wednesday curbed the use of certain antibiotics in cattle, pigs and poultry.

Widespread use of antibiotics in food-producing animals is thought to be a major source of antibiotic-resistant strains of bacteria, experts say.

The new ban includes antibiotics known as cephalosporins, and would take effect April 5, the FDA said in a statement.

The proposed rules, which apply to cattle, swine, chickens and turkeys, are intended to reduce the risk of cephalosporin resistance in certain types of bacteria so that the drugs remain effective in treating disease in humans.

The agency's move "will help to prevent the development of bacterial resistance to this class of drugs," said one expert, Dr. Pascal James Imperato, dean of the SUNY Downstate School of Public Health in New York City.

Another specialist in infectious disease agreed.

"If you use them, you lose them. Antibiotics that is," said Dr. Bruce Hirsch, an attending physician in infectious diseases at North Shore University Hospital in Manhasset, N.Y. "Bacteria are capable of reproducing every 20 to 30 minutes. Antibiotics -- particularly in the low doses used in animals -- exert a selection pressure [on bacteria] which results in antibiotic resistance."

Cephalosporins are used in humans to treat pneumonia, skin and soft tissue infections, pelvic inflammatory disease, diabetic foot infections and urinary tract infections.

If the drugs lose their effectiveness to treat these conditions, doctors may have to use less effective drugs or ones with greater side effects, the FDA explained.

"We believe this [move] is an imperative step in preserving the effectiveness of this class of important antimicrobials that takes into account the need to protect the health of both humans and animals," Michael R. Taylor, Deputy Commissioner for Foods, said in an FDA news release.

Under the new FDA order, prohibited (extra-label) uses of cephalosporins in cattle, swine, chickens and turkeys include:

  • unapproved dose levels, frequencies, durations, or routes of administration.
  • using cephalosporins that are not approved for use in those species but may be approved for humans or pets.
  • administering the drugs for disease prevention.

The order does not limit the use of cephapirin (Cefadyl), an older cephalosporin drug that's not believed to contribute significantly to antimicrobial resistance. Veterinarians will still be allowed to use or prescribe cephalosporins for limited extra-label use in cattle, swine, chickens or turkeys as long as they follow dose, frequency, duration and route of administration instructions on the label.

Extra-label use of the drugs will also be allowed in minor species of food-producing animals, such as rabbits or ducks.

"Cephalosporins are a widely used class of antibiotics that are vital in the treatment of a variety of human infections," Imperato noted. "Their widespread use in food-producing animals is usually undertaken in the interests of preventing certain infections in these animals. These infections in turn can delay animal growth as energy is expended fighting them off.

"However," he added, "the use of these antibiotics in animals also leads to the emergence of antibiotic resistant strains of bacteria. Thus, the FDA decision is a very wise one that will help to prevent the emergence of bacterial resistance and thus assure that this class of antibiotics will continue to be effective for treating human infections."

A comment period on the new order of prohibition begins Jan. 6 and closes March 6. Comments submitted during that time will be considered before the new rules take effect April 5.

More information

The World Health Organization has more about antimicrobial resistance.

-- Robert Preidt

SOURCES: Pascal J. Imperato, M.D., dean, SUNY Downstate School of Public Health, New York City; Bruce Hirsch, M.D., attending physician, Infectious Diseases, North Shore University Hospital, Manhasset, N.Y.; U.S. Food and Drug Administration, news release, Jan. 4, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Clue to How Chinese Remedy Curbs Drinking
2. HIV/AIDS treatment curbs spread of disease: UBC-BC CfE study
3. Black Book Joins AutoTec in Industry-Wide Effort to Stop Curbstoning
4. Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy
5. Heart drug may be effective for managing certain cancers: Queens University study
6. HIV Patients at Heightened Risk for Certain Cancers
7. Policymakers should prepare for major uncertainties with Medicaid expansion
8. Esophageal Cancer Risk Less Dire for Certain Patients: Study
9. Certain After-Stroke Treatments May Boost Outcome
10. Certain dietary supplements associated with increased risk of death in older women
11. Spinal Surgery Riskier for Certain Patients, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Curbs Use of Certain Antibiotics in Livestock, Poultry
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , ... and recognition opportunities as well as advocacy for the state and region‘s technology ... February 23. The Council's Innovation Forecast event highlights innovation throughout the region ...
(Date:2/24/2017)... ... 24, 2017 , ... Dr. Ronald E. Hawkins, vice president ... of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean ... Dr. Bell comes to Liberty from the Ohio University Heritage College of Osteopathic ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... In the ... to be a top priority because it’s not if you will be attacked, but ... especially when it comes to digital health care. , Improvements in auditing and monitoring ...
(Date:2/24/2017)... ... ... Healthcare Associates of McKinney announced today that they have moved ... Highway 121, Suite 210, McKinney, Texas 75070. It is in the heart of ... practice has grown, the need for more space has been paramount. This beautiful ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ProGlass Prism users now have the ability ... total control over position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass ... , With ProGlass Prism users are given the tools and effects to generate ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... Feb. 23, 2017 Visiomed, the French ... since 1997, is changing the landscape of healthcare ... patients with pro-active, custom-made solutions. Recognizing the rising ... and affordable healthcare without walls, Visiomed has launched ... developed with healthcare professionals that is empowering the ...
(Date:2/23/2017)... 2017  Genesis Healthcare Services has merged with Hospice ... by Bill Monast , President and CEO of ... Nathan Feltman , executives with Home Health Depot, Inc., ... This acquisition helps Hospice Cloud maintain its ... durable medical equipment (DME) solutions for the hospice industry. ...
Breaking Medicine Technology: